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Abstract: The aim of this study was to evaluate phalangeal bone quantitative ultrasound (QUS) parameters in patients 
with Raynaud phenomenon (RP) and relate it with nailfold capillaroscopy findings. Patients referring to our Rheumatol-
ogy Unit with RP were enrolled and studied for capillaroscopy alterations; bone quality profile was measured by QUS of 
the phalanxes: AD-SoS (Amplitude Dependent Speed of Sound) UBPI (Ultrasound Bone Profile Index), UBI (ultrasound 
Bone Index), Z score and T score were collected. One hundred thirty six females with RP had investigated for age, height, 
weight, Body Mass Index, previous diseases and therapies, menopausal age were enrolled. Nailfold capillaroscopy re-
vealed minor alterations (borderline capillary dilatation, no capillary loss) in 36.8% (Group I), major alterations (capillar-
ies definitely dilated, avascular areas, microbleeding) in 37.5% (Group II) and no significative alterations in 25.7% of pa-
tients (Group 0). A higher frequency of low QUS parameters in phalanxes was observed in group II when compared to 
group I or 0 (72.5% vs 54% vs 18%; p<0.01). With an ANOVA analysis we found a significant difference between the 
three groups in terms of Ad-SOS (Group II 1750±140; Group I 1890±132; Group 0 1990±167, p<0.001), UBPI (Group II 
0.21±0.17; Group I 0.36±0.21; Group 0 0.51±0.24, p<0.001), UBI (Group II 1.2±0.43; Group I 1.4±0.32; Group 0 
1.5±0.41, p<0.001), Z-scores (Group II -2.8±1.45; Group I -1.85±1.27; Group 0 -1.1±1.39, p<0.001) and T-scores (Group 
II -4.8±2.1; Group I -3.2±1.8; Group 0 -1.8±2.4, p<0.001). A standard linear regression analysis revealed an association 
between the capillaroscopy findings and QUS (R 0.47±0.8, p<0.01). In our study patients with capillaroscopy alterations 
showed reduced phalangeal quantitative ultrasound parameters, more markedly in patients with scleroderma pattern or 
other major capillaroscopy alterations, independently from confounding variables. 
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INTRODUCTION 
  Raynaud’s phenomenon (RP) is a vasospastic disorder 
characterized by episodic color changes of blanching, cyano-
sis, and hyperemia in response to cold and/or emotional 
stress. RP may be a primary or a secondary process, primar-
ily connective tissue diseases (CTDs). and scleroderma. 
  Nailfold videocapillaroscopy can describe and quantify 
the morphological characteristics of capillaries and distin-
guish different forms of connective tissue disease. Further-
more, low bone mass has been seen to occur in a significant 
percentage of patients with scleroderma or CTDs but few 
data are available up to date on the usefulness of quantitative 
ultrasound in the study of phalangeal bone quality and struc-
ture in primary and secondary RP. Aim of our study was to 
relate capillaroscopy alterations with bone quantitative ultra-
sound parameters (QUS) in patients with RP hypothizing 
that vascular alterations occurring in RP results in local 
lower bone quality and QUS values. 
MATERIALS AND METHODS 
Subjects 
  We studied females with RP, referring to our Rheuma-
tologic division, at the Fornaroli Hospital of Magenta (Italy), 
from September 2006 to April 2007. A detailed history was 
taken of each patient, with particular reference to age, RP  
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onset age, menopausal status, disease duration, current or 
previous treatments, and current or previous diseases; their 
height and weight were measured and related by the body 
mass index ratio (BMI). The following serological markers 
were determined: ESR, CRP, antinuclear antibodies, anticen-
tromere antibodies, anti-extractable nuclear antigen, includ-
ing anti-Scl70, Sm, RNP, SSB, SSA, and Jo1. Subjects were 
excluded if they had any history of a medical disorder known 
to affect bone metabolism or were on any medication that 
could affect bone mass, including use of corticosteroids or 
heparin, thyroid alterations, cancer, haemocromatosis, diabe-
tes mellitus. 
Methods 
  For this study we defined Raynaud's phenomenon as epi-
sodic well-demarcated hands pallor and/or cyanosis in re-
sponse to cold or emotional stress that was relieved by re-
warming. We measured bone ultrasound parameters at pha-
langes: the amplitude-dependent speed of sound (AD-SoS), 
broadband ultrasound attenuation (BUA), UBPI (Ultrasound 
Bone Profile Index), UBI (ultrasound Bone Index), fast wave 
amplitude (FWA), which is the maximum amplitude of the 
fastest peak of the received US signal; Z score and T score 
values (referred to healthy Italian population) were also col-
lected. Furthermore we performed a nailfold capillaroscopy 
on four fingers of both hands; all examinations were per-
formed by the same experienced rheumatologist (MGM). 
  All patients were thereafter clinically evaluated by an-
other experienced rheumatologist (AML) blind to the capil-
laroscopy results. The clinical diagnosis was used as gold 
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Statistical Analysis 
  All values were expressed as mean ± SD. An analysis of 
variance, simple (ANOVA) or with adjustment for some 
covariates (ANCOVA), was applied to compare the parame-
ters measured between groups. Linear regression analysis 
and stepwise multiple regression analysis were used to assess 
the relationships between variables collected. A p value 
lower than 0.05 was considered statistically significant. All 
statistical analyses were carried out with SPSS software. 
RESULTS 
  One hundred thirty six females with RP were enrolled. In 
whole population mean (±SD) age was 53.3 years (±14.1), 
mean BMI was 24.8(±7.8), mean menopausal age was 46.9 
(±5.4). The mean QUS parameters values were: AdSOS 
1881 (±159), FWA 28.7 (±9.8), UBI 1.32 (±0.38), UBPI 
0.34 (±0.22). The mean Z score and T score were -1.98 and -
3.4 respectively. Nailfold capillaroscopy revealed minor al-
terations (defined as: some tortuosity, borderline capillary 
dilatation, no capillary loss) in 36.8% (Group I), major al-
terations (defined as: capillaries definitely dilated, avascular 
areas, megacapillaries, microbleeding and capillary thrombo-
sis, angiogenesis) in 37.5% (Group II) and no significant 
alterations in 25.7% of patients (Group 0). No differences 
were present in age, menopausal age, BMI between groups 
(p>0.2). In group II we found: Ad-SOS 1750±140, UBPI 
0.21±0.17, UBI 12±0.43, Z-score -2.8±1.45 and T-score -
4.8±2.1; with a standard ANOVA with post hoc test all these 
values were significantly lower than group I and group 0, 
also correcting for all confounding variables collected. 
(p<0.01) (Figs. 1-3). 
  With a linear logistic test we found a Pearson R correla-
tion index of: 0.37±0.7 for Z-score, 0.41±0.5 for UBPI and 
0.47±0.8 for AdSOS (p<0.001). 
  The conclusive clinical evaluation of the whole popula-
tion revealed that the 88% of group II patients, 15% of group 
I patients and 1.7% of group 0 were affected by a major 
CTD including SSc (p<0.001). In all other cases a diagnosis 
of primary Raynaud was made. 
DISCUSSION 
  Raynaud’s phenomenon (RP) is a common clinical con-
dition in rheumatology, with microvascular involvement as 
key feature. LeRoy and Medsger suggested criteria for pri-
mary RP: symmetric attacks, the absence of tissue necrosis, 
ulceration or gangrene, the absence of a secondary cause, 
negative antinuclear antibodies, normal nailfold capillaro-
scopy and a normal erythrocyte sedimentation rate. Secon-
dary RP is characterized by an age of onset of more than 30 
years, painful and asymmetric attacks, ischemic skin lesions, 
positive autoautoantibodies, capillaroscopy major abnormali-
ties and/or clinical features suggestive of CTDs. Among the 
CTDs, scleroderma has the highest frequency of RP. Periph-
eral microangiopathy may be recognized by nailfold capil-
laroscopy, a non-invasive and safe technique that is reported 
to have both diagnostic and prognostic value. The peripheral 
microvascular damage in scleroderma is characterized by 
increasing structural alterations of the capillaries (giant capil-
laries and microhaemorrhages) with a progressive de-
crease in their density (scleroderma pattern). General-
ized radiological osteopenia has been seen to occur in a sig-
nificant percentage of patients with connective diffuse   
 
Fig. (1). Ad-SOS mean values related to capillaroscopy pattern (p<0.001). 
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diseases and scleroderma. Bone mineral content was found 
to be reduced at the radius, lumbar spine, and the total body. 
No data are available up to date on QUS evaluation of pha-
langeal bone in patients with primary or secondary RP [7-9]. 
Recently there has been a growing scientific and clinical 
interest in QUS as an alternative method to dual-energy X-
 
Fig. (2). UBPI mean values related to capillaroscopy pattern (p<0.001). 
 
Fig. (3). Z score mean values related to capillaroscopy pattern (p<0.001). 
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ray absorptiometry (DXA) for assessing skeletal status. QUS 
is thought to reflect not only bone density, but also some 
structural properties of bone, such as elasticity and trabecular 
stiffness and connectivity, which could be closely connected 
to bone strength [10, 11]. Up to date no data are present in 
literature about bone quality parameters or bone mass indices 
of hand fingers phalanxes, that are primarily affected during 
RP. In our study we used QUS instead DEXA for studying 
not only bone density but primarily bone quality. Our results 
seems confirming literature, showing that patients with ma-
jor capillaroscopy alterations are affected more likely by 
CTDs and are characterized by generalized osteopenia or 
osteoporosis. Finally, also the bone quality indices seems to 
be altered, suggesting a bone sufferance caused by local mi-
crovascular damages. 
CONCLUSION 
  Data collected in our study suggest that RP, primarily in 
patients with scleroderma other CTDs, modify phalangeal 
bone mass, bone density, and bone quality with a good corre-
lation between nailfold patterns and QUS, independently 
from confounding variables. 
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